These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9825730

  • 21. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
    Carnaghi C, Zucali P, Garassino I.
    Tumori; 2000; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
    Houghton JA, Cheshire PJ, Hallman JD, Lutz L, Luo X, Li Y, Houghton PJ.
    Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
    [Abstract] [Full Text] [Related]

  • 24. Nanoparticle delivery of an SN38 conjugate is more effective than irinotecan in a mouse model of neuroblastoma.
    Iyer R, Croucher JL, Chorny M, Mangino JL, Alferiev IS, Levy RJ, Kolla V, Brodeur GM.
    Cancer Lett; 2015 May 01; 360(2):205-12. PubMed ID: 25684664
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Experimental study of effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with irinotecan].
    Xu JM, Li YM, Wang Y, Zhao CH, Yuan SJ, Yang WW, Li ZQ, Han Y, Azzariti A, Paradiso A.
    Zhonghua Zhong Liu Za Zhi; 2006 Aug 01; 28(8):578-82. PubMed ID: 17236550
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Chemotherapy for colorectal cancer.
    Goyle S, Maraveyas A.
    Dig Surg; 2005 Aug 01; 22(6):401-14. PubMed ID: 16479107
    [Abstract] [Full Text] [Related]

  • 30. Irinotecan and DNA-PKcs inhibitors synergize in killing of colon cancer cells.
    Davidson D, Coulombe Y, Martinez-Marignac VL, Amrein L, Grenier J, Hodkinson K, Masson JY, Aloyz R, Panasci L.
    Invest New Drugs; 2012 Jun 01; 30(3):1248-56. PubMed ID: 21221710
    [Abstract] [Full Text] [Related]

  • 31. In vitro cytotoxicity, pharmacokinetics and tissue distribution in rats of MXN-004, a novel conjugate of polyethylene glycol and SN38.
    Zhou S, Li N, Wang X, Li C, Tian F, Ren S, Zhang Y, He Y, Qiu Z, Zhao D, Chen X.
    Xenobiotica; 2014 Jun 01; 44(6):562-9. PubMed ID: 24308437
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins.
    Zuco V, De Cesare M, Zaffaroni N, Lanzi C, Cassinelli G.
    Oncotarget; 2015 Apr 20; 6(11):8736-49. PubMed ID: 25826089
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
    Du Y, Zhang W, He R, Ismail M, Ling L, Yao C, Fu Z, Li X.
    Bioorg Med Chem; 2017 Jun 15; 25(12):3247-3258. PubMed ID: 28465086
    [Abstract] [Full Text] [Related]

  • 37. Vorinostat enhances the cytotoxic effects of the topoisomerase I inhibitor SN38 in glioblastoma cell lines.
    Sarcar B, Kahali S, Chinnaiyan P.
    J Neurooncol; 2010 Sep 15; 99(2):201-7. PubMed ID: 20135194
    [Abstract] [Full Text] [Related]

  • 38. Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in p53 mutant human colon cancer.
    Tanaka K, Inoue Y, Hiro J, Yoshiyama S, Toiyama Y, Eguchi T, Miki C, Kusunoki M.
    J Exp Clin Cancer Res; 2007 Jun 15; 26(2):241-51. PubMed ID: 17725105
    [Abstract] [Full Text] [Related]

  • 39. In vitro antitumor activity of 9-nitro-camptothecin as a single agent and in combination with other antitumor drugs.
    Bernacki RJ, Pera P, Gambacorta P, Brun Y, Greco WR.
    Ann N Y Acad Sci; 2000 Jun 15; 922():293-7. PubMed ID: 11193904
    [Abstract] [Full Text] [Related]

  • 40. Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer.
    Comella P, Massidda B, Palmeri S, Putzu C, De Rosa V, Izzo F, Fiore F, Casaretti R, Sandomenico C.
    Anticancer Drugs; 2006 Sep 15; 17(8):985-92. PubMed ID: 16940809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.